Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population

JAMA Psychiatry

Volumn 73, Issue 3, 2016, Pages 221-228

  Jones, Hannah J ^a,b   Stergiakouli, Evie ^b   Tansey, Katherine E ^b   Hubbard, Leon ^c   Heron, Jon ^a   Cannon, Mary ^d   Holmans, Peter ^c   Lewis, Glyn ^e   Linden, David E J ^c   Jones, Peter B ^f   Smith, George Davey ^b   O'Donovan, Michael C ^c   Owen, Michael J ^c   Walters, James T ^c   Zammit, Stanley ^a,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; ONSET AGE; OUTCOME ASSESSMENT; PHENOTYPE; POLYGENIC RISK SCORE; QUALITY CONTROL; SCHIZOPHRENIA; SCHIZOPHRENIA ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT; ADOLESCENT BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADOLESCENT BEHAVIOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA;

EID: 84962567847     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.3058     Document Type: Article

References (47)

1. SchizophreniaWorking Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-427.
2. Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: ameta-analysis of family high-risk studies. Schizophr Bull. 2014;40(1):28-38.
3. Ripke S, O'Dushlaine C, Chambert K, et al; Multicenter Genetic Studies of Schizophrenia Consortium; Psychosis Endophenotypes International Consortium;Wellcome Trust Case Control Consortium 2. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45(10):1150-1159.
4. Purcell SM,Wray NR, Stone JL, et al; International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256):748-752.
5. Krapohl E, Euesden J, Zabaneh D, et al. Phenome-wide analysis of genome-wide polygenic scores [published online August 25, 2015]. Mol Psychiatry. doi:10.1038/mp.2015.126.
6. Buckley PF,Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35(2):383-402.
7. Docherty JP, Van Kammen DP, Siris SG, Marder SR. Stages of onset of schizophrenic psychosis. Am J Psychiatry. 1978;135(4):420-426.
8. Tien AY, EatonWW. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry. 1992;49(1):37-46.
9. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344 (8934):1398-1402.
10. Turnbull G, Bebbington P. Anxiety and the schizophrenic process: clinical and epidemiological evidence. Soc Psychiatry Psychiatr Epidemiol. 2001; 36(5):235-243.
11. Khandaker GM, Barnett JH, White IR, Jones PB. A quantitativemeta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res. 2011;132(2-3):220-227.
12. Lee SH, Ripke S, Neale BM, et al; Cross-Disorder Group of the Psychiatric Genomics Consortium; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-994.
13. HamshereML, Stergiakouli E, Langley K, et al. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. Br J Psychiatry. 2013;203(2):107-111.
14. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875):1371-1379.
15. Demirkan A, Penninx BW, Hek K, et al. Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry. 2011;16(7):773-783.
16. Derks EM, Vorstman JAS, Ripke S, Kahn RS, Ophoff RA; Schizophrenia Psychiatric Genomic Consortium. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. PLoS One. 2012;7(6):e37852.
17. Sieradzka D, Power RA, Freeman D, et al. Are genetic risk factors for psychosis also associated with dimension-specific psychotic experiences in adolescence? PLoS One. 2014;9(4):e94398.
18. Zammit S, Hamshere M, Dwyer S, et al. A population-based study of genetic variation and psychotic experiences in adolescents. Schizophr Bull. 2014;40(6):1254-1262.
19. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013;9(3): e1003348.
20. Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42(1):97-110.
21. Boyd A, Golding J, Macleod J, et al. Cohort profile: the "children of the 90s": the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013;42(1):111-127.
22. Horwood J, Salvi G, Thomas K, et al. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry. 2008;193(3):185-191.
23. Zammit S, Kounali D, Cannon M, et al. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry. 2013;170(7):742-750.
24. Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32(2):347-358.
25. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development andWell-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry. 2000; 41(5):645-655.
26. Goodman A, Heiervang E, Collishaw S, Goodman R. The "DAWBA bands" as an ordered-categorical measure of child mental health: description and validation in British and Norwegian samples. Soc Psychiatry Psychiatr Epidemiol. 2011; 46(6):521-532.
27. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
28. Iyegbe C, Campbell D, Butler A, Ajnakina O, Sham P. The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research. Soc Psychiatry Psychiatr Epidemiol. 2014;49(2):169-182.
29. Amemiya T. Qualitative response models: a survey. J Econ Lit. 1981;19(4):1483-1536.
30. Kounali D, Zammit S,Wiles N, et al. Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence. Psychol Med. 2014;44(12):2557-2566.
31. Fratiglioni L,Wang HX. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav Brain Res. 2000;113 (1-2):117-120.
32. Bendall S, Jackson HJ, Hulbert CA, McGorry PD. Childhood trauma and psychotic disorders: a systematic, critical review of the evidence. Schizophr Bull. 2008;34(3):568-579.
33. Kelleher I, Keeley H, Corcoran P, et al. Childhood trauma and psychosis in a prospective cohort study: cause, effect, and directionality. Am J Psychiatry. 2013;170(7):734-741.
34. Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328.
35. McIntosh AM, Gow A, Luciano M, et al. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biol Psychiatry. 2013;73(10):938-943.
36. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia: psychopathological and behavioral correlates. Eur Psychiatry. 2002;17 (1):9-16.
37. Heinz A, Schlagenhauf F. Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull. 2010;36(3):472-485.
38. Hubbard L, Tansey KE, Rai D, et al. Evidence of common genetic overlap between schizophrenia and cognition [published online December 16, 2015]. Schizophr Bull.
39. Dworkin RH, Lenzenweger MF, Moldin SO, Skillings GF, Levick SE. A multidimensional approach to the genetics of schizophrenia. Am J Psychiatry. 1988;145(9):1077-1083.
40. Zavos HM, Freeman D, Haworth CM, et al. Consistent etiology of severe, frequent psychotic experiences and milder, less frequent manifestations: a twin study of specific psychotic experiences in adolescence. JAMA Psychiatry. 2014; 71(9):1049-1057.
41. Sieradzka D, Power RA, Freeman D, Cardno AG, Dudbridge F, Ronald A. Heritability of individual psychotic experiences captured by common genetic variants in a community sample of adolescents. Behav Genet. 2015;45(5):493-502.
42. Fanous AH, Zhou B, Aggen SH, et al; Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry. 2012;169 (12):1309-1317.
43. Schulze TG, Akula N, Breuer R, et al; Bipolar Genome Study. Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder.World J Biol Psychiatry. 2014;15(3):200-208.
44. Pallanti S, Cantisani A, Grassi G. Anxiety as a core aspect of schizophrenia. Curr Psychiatry Rep. 2013;15(5):354.
45. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull. 2014;40(1):120-131.
46. Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med. 2014;44(1):17-24.
47. Martin J, Tilling K, Hubbard L, et al. Genetic risk for schizophrenia associated with non-participation over time in a population-based cohort study. Am J Epidemiol. In press.